Matters
- Represented a private equity sponsor in its $2.1 billion acquisition of a majority interest in a national oncology practice network.
- Represented a private equity sponsor in its acquisition of a majority stake in a health care consulting business, establishing it as an independent entity.
- Represented a publicly traded portfolio company of a private equity sponsor in its secondary public offering of 11.5 million shares of common stock.
- Represented a global insurance organization and its majority-owned subsidiary in the subsidiary’s initial public offering.
- Represented a publicly traded portfolio company of a private equity sponsor in its secondary public offering of 9.2 million shares of common stock.
